Cogent Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $71.6M | $327.9M | $98.2M |
| FY2025 | $301.2M | $937.6M | $312.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $71.6M | $327.9M | $98.2M |
| FY2025 | $301.2M | $937.6M | $312.0M |